Loading
A phase 1/2 trial of IPN01194 in melanoma, head and neck squamous cell carcinoma, pancreatic ductal adenocarcinoma and colorectal cancer, run by Ipsen, active and no longer recruiting.
A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours is a phase 1/2 interventional study registered as NCT06305247 by Ipsen, with 36 participants enrolled, started 2024-04-03 and due to reach its primary completion in 2028-03-20. Interventions recorded: IPN01194.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Head and neck squamous cell carcinoma, Pancreatic ductal adenocarcinoma, Colorectal cancer and the tag pipeline.
Shares Head and neck squamous cell carcinoma, Pancreatic ductal adenocarcinoma, Colorectal cancer and the tag pipeline.
Shares Pancreatic ductal adenocarcinoma, Colorectal cancer and the tag pipeline.
Shares Ipsen and the tag pipeline.
Shares Ipsen and the tag pipeline.
Shares Ipsen and the tag pipeline.
Shares Ipsen and the tag pipeline.
Shares Head and neck squamous cell carcinoma, Melanoma and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/